glp-1 suicidal ideation Understanding the link between GLP-1 therapies and suicidal ideation using real-world data

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study | Diabetologia

20.77

★★★★☆4.8 (126)

FDA Moves To Remove Suicide Warnings From GLP-1 Weight Loss Drugs

28.39

★★★★★4.9 (98)

The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the agency announced on

21.88

★★★★★5.0 (157)

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes: A Target Trial Emulation Study: Annals of Internal Medicine: Vol 177, No 8

21.71

★★★★★4.7 (84)

GLP-1 treatment lowers suicidal ideation risk by 33% in adolescents with obesity, study finds

22.85

★★★★★4.9 (203)

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study

25.68

★★★★★5.0 (176)

The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw

21.35

★★★★★4.8 (132)